Our findings on the tumor suppressive nature of EIF4G2 in EC contradict previous in-depth analysis of EIF4G2 function in metastatic triple negative breast cancer, in which EIF4G2 was shown to promote metastasis through translation of factors associated with EMT, motility, angiogenesis and cell survival [21]. The gene discussed is EIF4G2; the disease is triple-negative breast carcinoma.